
Today's pharmaceutical industry faces many challenges as drug development costs continue to climb, pricing pressures mount, and new global markets gain critical importance.
Dr. Satish Tadikonda is a 25-year pharma industry veteran and CEO/Founder of Virtify, Inc, a content and regulatory information management solution company for life sciences. Prior to Virtify, Dr. Tadikonda was the founder of Tribiosys, Inc., and CEO/President of Enmed, a clinical trial and data management systems company. Dr. Tadikonda holds a Doctorate in Electrical and Computer Engineering from the University of Iowa, and a Bachelor of Technology in Electrical and Electronics Engineering from Birla Institute of Technology and Science, India. He has published and presented more than 30 articles in peer-reviewed journals and international conferences on topics in global labeling, medical imaging, clinical trial data management/disclosure, and technology in the life sciences.

Published: October 30th 2013 | Updated: